{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:41:41Z","timestamp":1783186901225,"version":"3.54.6"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"13","license":[{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MDA238981"],"award-info":[{"award-number":["MDA238981"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21NS58429S"],"award-info":[{"award-number":["R21NS58429S"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21NS58429-01A1"],"award-info":[{"award-number":["R21NS58429-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR053697"],"award-info":[{"award-number":["R01AR053697"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR064338-01A1"],"award-info":[{"award-number":["R01AR064338-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1093\/hmg\/ddz044","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T20:16:09Z","timestamp":1550866569000},"page":"2120-2132","source":"Crossref","is-referenced-by-count":22,"title":["Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy"],"prefix":"10.1093","volume":"28","author":[{"given":"Tatiana M","family":"Fontelonga","sequence":"first","affiliation":[{"name":"Department of Pharmacology, University of Nevada, Reno School of Medicine, , Reno, NV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brennan","family":"Jordan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Nevada, Reno School of Medicine, , Reno, NV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia M","family":"Nunes","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Nevada, Reno School of Medicine, , Reno, NV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Barraza-Flores","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Nevada, Reno School of Medicine, , Reno, NV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Bolden","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Nevada, Reno School of Medicine, , Reno, NV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D","family":"Wuebbles","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Nevada, Reno School of Medicine, , Reno, NV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley Mathews","family":"Griner","sequence":"additional","affiliation":[{"name":"Division of Pre-clinical Innovation, NIH Center for Advancing Translational Sciences, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[{"name":"Division of Pre-clinical Innovation, NIH Center for Advancing Translational Sciences, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ferrer","sequence":"additional","affiliation":[{"name":"Division of Pre-clinical Innovation, NIH Center for Advancing Translational Sciences, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Marugan","sequence":"additional","affiliation":[{"name":"Division of Pre-clinical Innovation, NIH Center for Advancing Translational Sciences, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Southall","sequence":"additional","affiliation":[{"name":"Division of Pre-clinical Innovation, NIH Center for Advancing Translational Sciences, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J","family":"Burkin","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Nevada, Reno School of Medicine, , Reno, NV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"key":"2019062010401263000_ref1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/jpc.12868","article-title":"Duchenne muscular dystrophy","volume":"51","author":"Yiu","year":"2015","journal-title":"J. Paediatr. Child Health"},{"key":"2019062010401263000_ref2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"2019062010401263000_ref3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0092-8674(88)90065-7","article-title":"Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface","volume":"54","author":"Bonilla","year":"1988","journal-title":"Cell"},{"key":"2019062010401263000_ref4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0959-437X(02)00309-X","article-title":"Muscular dystrophies involving the dystrophin\u2013glycoprotein complex: an overview of current mouse models","volume":"12","author":"Durbeej","year":"2002","journal-title":"Curr. Opin. Genet. Dev."},{"key":"2019062010401263000_ref5","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.bbapap.2010.05.001","article-title":"Dystrophin: more than just the sum of its parts","volume":"1804","author":"Le Rumeur","year":"2010","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"2019062010401263000_ref6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1085\/jgp.201010436","article-title":"Mechanisms of muscle weakness in muscular dystrophy","volume":"136","author":"Goldstein","year":"2010","journal-title":"J. Gen. Physiol."},{"key":"2019062010401263000_ref7","first-page":"184","article-title":"The role of fibrosis in Duchenne muscular dystrophy Werner","volume":"31","author":"Klingler","year":"2012","journal-title":"Acta Myol."},{"key":"2019062010401263000_ref8","first-page":"866","article-title":"Stem cell differentiation toward the myogenic lineage for muscle tissue regeneration: a focus on muscular dystrophy","volume-title":"Stem Cell Rev and Rep.","author":"Ostrovidov","year":"2015"},{"key":"2019062010401263000_ref9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ncl.2014.05.002","article-title":"Duchenne and Becker muscular dystrophies","volume":"32","author":"Flanigan","year":"2014","journal-title":"Neurol. Clin."},{"key":"2019062010401263000_ref10","first-page":"249","article-title":"Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade","volume-title":"Neuromuscular Disorders","author":"Biggar","year":"2006"},{"key":"2019062010401263000_ref11","first-page":"785","article-title":"Long-term outcomes of steroid therapy for Duchenne muscular dystrophy in Japan","volume-title":"Brain & Development","author":"Goto","year":"2016"},{"key":"2019062010401263000_ref12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DDDT.S97635","article-title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","volume":"11","author":"Lim","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"2019062010401263000_ref13","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/nm.3990","article-title":"Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division","volume":"21","author":"Dumont","year":"2015","journal-title":"Nat. Med."},{"key":"2019062010401263000_ref14","first-page":"1","article-title":"Extracellular matrix regulation in the muscle satellite cell niche","volume-title":"Connect Tissue Res.","author":"Thomas"},{"key":"2019062010401263000_ref15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrm.2016.7","article-title":"Molecular circuitry of stem cell fate in skeletal muscle regeneration, ageing and disease","volume":"17","author":"Almada","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2019062010401263000_ref16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.molmed.2016.04.002","article-title":"Satellite cells in muscular dystrophy\u2014lost in polarity","volume":"22","author":"Chang","year":"2016","journal-title":"Trends Mol. Med."},{"key":"2019062010401263000_ref17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cmet.2007.11.011","article-title":"Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy","volume":"7","author":"Serrano","year":"2008","journal-title":"Cell Metab."},{"key":"2019062010401263000_ref18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006027","article-title":"Association of interleukin-6 signalling with the muscle stem cell response following muscle-lengthening contractions in humans","volume-title":"Plosone","author":"Mckay","year":"2009"},{"key":"2019062010401263000_ref19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017392","article-title":"IL-6 induced STAT3 signalling is associated with the proliferation of human muscle satellite cells following acute muscle damage","volume":"6","author":"Toth","year":"2011","journal-title":"PLoS One"},{"key":"2019062010401263000_ref20","volume-title":"Plosone","author":"Na\u00eb Lle Begue","year":"2013"},{"key":"2019062010401263000_ref21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/cpr.12045","article-title":"Interleukin-6-induced satellite cell proliferation is regulated by induction of the JAK2\/STAT3 signalling pathway through cyclin D1 targeting","volume":"46","author":"Kurosaka","year":"2013","journal-title":"Cell Prolif."},{"key":"2019062010401263000_ref22","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.celrep.2016.07.041","article-title":"STAT3 Regulates self-renewal of adult muscle satellite cells during injury-induced muscle regeneration","volume":"16","author":"Zhu","year":"2016","journal-title":"Cell Rep."},{"key":"2019062010401263000_ref23","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1177\/002215540205001202","article-title":"In vivo activation of STAT3 signaling in satellite cells and myofibers in regenerating rat skeletal muscles","volume":"50","author":"Kami","year":"2002","journal-title":"J. Histochem. Cytochem."},{"key":"2019062010401263000_ref24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cyto.2008.12.015","article-title":"STAT3 induces muscle stem cell differentiation by interaction with myoD","volume":"46","author":"Yang","year":"2009","journal-title":"Cytokine"},{"key":"2019062010401263000_ref25","first-page":"C128","article-title":"Interleukin-6 promotes myogenic differentiation of mouse skeletal muscle cells: role of the STAT3 pathway","volume-title":"Am J Physiol Cell Physiol.","author":"Hoene"},{"key":"2019062010401263000_ref26","doi-asserted-by":"crossref","article-title":"The JAK2\/STAT3 signal pathway regulates the expression of genes related to skeletal muscle development and energy metabolism in mice and mouse skeletal muscle cells","author":"Liu","DOI":"10.1271\/bbb.120324"},{"key":"2019062010401263000_ref27","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/nm.3655","article-title":"Inhibition of JAK-STAT signaling stimulates adult satellite cell function","volume":"20","author":"Price","year":"2014","journal-title":"Nat. Med."},{"key":"2019062010401263000_ref28","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/nm.3656","article-title":"STAT3 signaling controls satellite cell expansion and skeletal muscle repair","volume":"10","author":"Tierney","year":"2014","journal-title":"Nat. Med."},{"key":"2019062010401263000_ref29","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1242\/jcs.110.22.2873","article-title":"Altered expression of the \u03b17\u03b21 integrin in human and murine muscular dystrophies","volume":"110","author":"Hodges","year":"1997","journal-title":"J. Cell Sci."},{"key":"2019062010401263000_ref30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/ng0598-94","article-title":"Mutations in the integrin alpha7 gene cause congenital myopathy","volume":"1","author":"Hayashi","year":"1998","journal-title":"Nat. Genet."},{"key":"2019062010401263000_ref31","first-page":"182","volume-title":"Cell Tissue Res","author":"Burkin","year":"1999"},{"key":"2019062010401263000_ref32","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1083\/jcb.152.6.1207","article-title":"Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice","volume":"152","author":"Burkin","year":"2001","journal-title":"J. Cell Biol."},{"key":"2019062010401263000_ref33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-9440(10)62249-3","article-title":"Transgenic expression of alpha7beta1 integrin (2005)","volume":"166","author":"Burkin","year":"2005","journal-title":"Am. J. Pathol."},{"key":"2019062010401263000_ref34","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/hmg\/ddl018","article-title":"Absence of a7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy","volume":"15","author":"Guo","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"2019062010401263000_ref35","first-page":"2185","volume-title":"J. Cell Sci","author":"Rooney","year":"2006"},{"key":"2019062010401263000_ref36","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1093\/hmg\/dds271","article-title":"Dystrophin and utrophin expression require sarcospan: loss of a7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice","volume":"21","author":"Marshall","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"2019062010401263000_ref37","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1152\/japplphysiol.00602.2013","article-title":"Alpha 7 integrin preserves the function of the extensor digitorum longus","volume":"115","author":"Hakim","year":"2013","journal-title":"J. Appl. Physiol."},{"key":"2019062010401263000_ref38","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/mt.2012.281","article-title":"AAV-mediated overexpression of human \u03b17 integrin leads to histological and functional improvement in dystrophic mice","volume":"21","author":"Heller","year":"2013","journal-title":"Mol. Ther."},{"key":"2019062010401263000_ref39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/hum.2015.062","article-title":"Human a7 integrin gene (ITGA7) delivered by adeno-associated virus extends survival of severely affected dystrophin\/utrophin-deficient mice","volume":"26","author":"Heller","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"2019062010401263000_ref40","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ymthe.2017.03.022","article-title":"SU9516 Increases \u03b17\u03b21 integrin and ameliorates disease progression in the mdx mouse model of Duchenne muscular dystrophy","volume":"25","author":"Sarathy","year":"2017","journal-title":"Mol. Ther."},{"key":"2019062010401263000_ref41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.2005.02.2194","article-title":"Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer","volume":"24","author":"Faivre","journal-title":"J. Clin. Oncol."},{"key":"2019062010401263000_ref42","doi-asserted-by":"crossref","DOI":"10.1007\/s00280-006-0376-5","article-title":"Sunitinib malate","author":"Izzedine","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2019062010401263000_ref43","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.18632\/oncotarget.2812","article-title":"Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle","volume":"6","author":"Pretto","year":"2014","journal-title":"Oncotarget"},{"key":"2019062010401263000_ref44","first-page":"22915","article-title":"Identification and characterization of the cell type-specific and developmentally regulated \u03b17 integrin gene promoter","volume-title":"The Journal of Biol Chem.","author":"Ziober"},{"key":"2019062010401263000_ref45","author":"Jethanandani","year":"2005"},{"key":"2019062010401263000_ref46","doi-asserted-by":"crossref","article-title":"Developmental myosins: expression patterns and functional significance","author":"Schiaffino","DOI":"10.1186\/s13395-015-0046-6"},{"key":"2019062010401263000_ref47","doi-asserted-by":"crossref","first-page":"965631","DOI":"10.1155\/2014\/965631","article-title":"Understanding the process of fibrosis in Duchenne muscular dystrophy","volume":"2014","author":"Kharraz","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"2019062010401263000_ref48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/physrev.00043.2011","article-title":"Satellite cells and the muscle stem cell niche","volume":"93","author":"Yin","year":"2013","journal-title":"Physiol. Rev."},{"key":"2019062010401263000_ref49","first-page":"179","volume-title":"Methods Mol. Biol.","author":"Dumont","year":"2017"},{"key":"2019062010401263000_ref50","first-page":"6508","article-title":"STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation","volume-title":"Mol and Cell Biol.","author":"Chung","year":"1997"},{"key":"2019062010401263000_ref51","first-page":"11107","article-title":"Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases","volume":"95","author":"Sengupta","year":"1998","journal-title":"Biochemistry"},{"key":"2019062010401263000_ref52","first-page":"800","article-title":"Sorafenib and Sunitinib learning objectives","volume-title":"The Oncologist","author":"Kim"},{"key":"2019062010401263000_ref53","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1593\/neo.09166","article-title":"In vivo antitumor and antimetastatic activity of Sunitinib in preclinical neuroblastoma mouse model 1","volume":"11","author":"Zhang","year":"2009","journal-title":"Neoplasia"},{"key":"2019062010401263000_ref54","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1158\/1078-0432.CCR-11-0237","article-title":"Phase I and pharmacokinetic study of Sunitinib in pediatric patients with refractory solid tumors: a Children\u2019s Oncology Group study","volume":"17","author":"Dubois","journal-title":"Clin. Cancer Res."},{"key":"2019062010401263000_ref55","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00280-011-1798-2","article-title":"Tolerability and pharmacokinetic profile of a Sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children\u2019s Oncology Group study","volume":"69","author":"Dubois","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2019062010401263000_ref56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2014.00001","article-title":"Muscle satellite cell heterogeneity and self-renewal","volume":"2","author":"Motohashi","year":"2014","journal-title":"Front. Cell Dev. Biol."},{"key":"2019062010401263000_ref57","article-title":"Molecular circuitry of stem cell fate in skeletal muscle regeneration, ageing and disease","volume":"17","author":"Almada","year":"2016","journal-title":"Nat. Publ. Gr."},{"key":"2019062010401263000_ref58","first-page":"C204","article-title":"Multiple signaling pathways mediate LIF-induced skeletal muscle satellite cell proliferation","volume-title":"Am J Physiol Cell Physiol.","author":"Spangenburg"},{"key":"2019062010401263000_ref59","first-page":"2185","volume-title":"J Cell Sci. England","author":"Rooney","year":"2006"},{"key":"2019062010401263000_ref60","doi-asserted-by":"crossref","first-page":"C938","DOI":"10.1152\/ajpcell.00515.2010","article-title":"The \u03b17\u03b21-integrin accelerates fiber hypertrophy and myogenesis following a single bout of eccentric exercise","volume":"301","author":"Lueders","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2019062010401263000_ref61","first-page":"1","article-title":"Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6","volume-title":"Springer Plus","author":"Beliz\u00e1rio","year":"2016"},{"key":"2019062010401263000_ref62","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1042\/bj20030104","article-title":"Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2","volume":"372","author":"Fairlie","year":"2003","journal-title":"Biochem. J."},{"key":"2019062010401263000_ref63","first-page":"2284","article-title":"Hepatocyte growth factor (HGF) signals through SHP2 to regulate primary mouse myoblast proliferation","volume-title":"Exp Cell Res.","author":"Li"},{"key":"2019062010401263000_ref64","first-page":"61","article-title":"oinheritance of Noonan syndrome and Becker muscular dystrophy","volume-title":"Neuromuscular Disorders","author":"Dinopoulos"},{"key":"2019062010401263000_ref65","first-page":"1","article-title":"Isometric and eccentric force generation assessment of skeletal muscles isolated from murine models of muscular dystrophies video link","volume":"71","author":"Moorwood","year":"2013","journal-title":"J. Vis. Exp."},{"key":"2019062010401263000_ref66","first-page":"2","article-title":"The superhealing MRL background improves muscular dystrophy","volume":"2","author":"Heydemann","journal-title":"Skelet. Muscle"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/28\/13\/2120\/28848055\/ddz044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T12:26:56Z","timestamp":1662985616000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/28\/13\/2120\/5365303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,26]]},"references-count":66,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2019,2,26]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddz044","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7,1]]},"published":{"date-parts":[[2019,2,26]]},"article-number":"e17392"}}